Azithromycin for newborns to support early health
Part of Hormones & metabolism, Infections, Women’s health & pregnancy clinical trials.
This trial tests whether giving azithromycin to newborns who are smaller at birth can improve health outcomes in the first weeks of life. Your baby may be eligible if they meet specific age, feeding, and safety requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is 1 to 27 days old
- Baby weighs under 2500 g at enrollment and/or has low weight for length (z-score below -2)
- Baby weighs at least 1500 g at enrollment and can feed by mouth
- Baby has no fever and no known allergy to azithromycin or similar antibiotics (macrolides)
- At least one caregiver is age 18+ and agrees to sign consent
- Family plans to stay in the study area for at least 6 months, and baby is not a hospital inpatient or being transferred
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether adding the antibiotic azithromycin to standard nutritional care helps young children with severe acute malnutrition recover better. It is for children aged 6 to 59 months in Burkina Faso who have uncomplicated malnutrition and are not currently on antibiotics.
This trial tests whether giving azithromycin during labor can prevent infections in mothers and newborns. It is for pregnant women who are otherwise healthy and have no risk factors for infection.
This trial tests whether a single dose of the antibiotic azithromycin before a planned C-section can prevent infections after delivery. It is for pregnant people with a singleton or twins who are not in labor or have not had their water break.
This trial tests whether a low-dose antibiotic (azithromycin) can prevent lung infections in young children with structural lung damage. It aims to see if taking it regularly can keep their lungs healthier and reduce the need for antibiotics.
This trial tests whether azithromycin (an antibiotic) can improve outcomes for babies and young children in the ICU who have RSV causing serious breathing problems. It mainly looks at children who start strong breathing support soon after RSV symptoms begin.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
Hear when a new Infectious Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.